Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors

Podobne zapisy

• Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
  od: Ogata, Ryohei, i wsp.
  Wydane: (2020)
• Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer
  od: Syn, Nicholas LX, i wsp.
  Wydane: (2018)
• Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
  od: Thill, Marc, i wsp.
  Wydane: (2018)
• Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
  od: Tavakolian, Shaian, i wsp.
  Wydane: (2020)
• Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
  od: Finn, Richard S., i wsp.
  Wydane: (2016)